Neurovance Appoints Brigitte Robertson, MD, Vice President, Clinical Development

Neurovance, Inc. today announced that Brigitte Robertson, MD, has been appointed Vice President of Clinical Development. Dr. Robertson brings Neurovance nearly 20 years of expertise as a board certified adult, child and adolescent psychiatrist specializing in attention deficit hyperactivity disorder (ADHD), with over 15 years of clinical development experience focused on ADHD treatments. Most recently, Dr. Robertson served as Global Development Strategy Team Lead, Senior Director at Shire Pharmaceuticals, where she led multiple cross-functional global development teams and was accountable for the development strategy and execution for several development programs in ADHD involving Intuniv, SPD465 and Vyvanse, the leading . . .